Inflammation keeps people alive, but when it fails to switch off, it quietly drives pain, disability, and organ damage.
HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development ...